Article
Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors
11 Mar 2019
Abstract excerpt
Aim: Genomically matched trials in primary brain tumors (PBTs) require recent tumor sequencing. We evaluated whether circulating tumor DNA (ctDNA) could facilitate genomic interrogation in these patients. Methods: Data from 419 PBT patients tested clinically with a ctDNA NGS panel at a CLIA-certified laboratory were analyzed. Results: A total of 211 patients (50%) had ≥1 somatic alteration detected. Detection was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
